OvaScience Reports Second Quarter Fiscal 2013 Financial Results
8/13/2013 6:39:10 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
OvaScienceSM, (NASDAQ: OVAS), a life sciences company focused on the discovery, development and commercialization of new treatments for infertility, today reported financial results for the quarter ended June 30, 2013, and highlighted the Company’s recent accomplishments.
“Obtaining a NASDAQ listing for our common stock was a significant milestone for the Company this past quarter, completing our planned transition to the global capital market,” said Michelle Dipp, M.D., Ph.D., Chief Executive Officer of OvaScience.
Hey, check out all the research scientist jobs. Post your resume today!
comments powered by